Experienced in Primary Localized Cutaneous Amyloidosis

Andrea M. Collins

Sydney Street, 
London, ENG, GB 
Experienced in Primary Localized Cutaneous Amyloidosis
Sydney Street, 
London, ENG, GB 
OverviewLocationsClinical Research

Overview

Andrea Collins practices in London, United Kingdom. Ms. Collins is rated as an Experienced expert by MediFind in the treatment of Primary Localized Cutaneous Amyloidosis. Her top areas of expertise are Strep Throat, Pneumonia, Primary Localized Cutaneous Amyloidosis, and Severe Acute Respiratory Syndrome (SARS).

Her clinical research consists of co-authoring 85 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Primary Localized Cutaneous Amyloidosis.

Gender
Female

Locations

Sydney Street, London, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 2/3 Study to Determine the Efficacy, Safety and Immunogenicity of the Candidate Coronavirus Disease (COVID-19) Vaccine ChAdOx1 nCoV-19
A Phase 2/3 Study to Determine the Efficacy, Safety and Immunogenicity of the Candidate Coronavirus Disease (COVID-19) Vaccine ChAdOx1 nCoV-19
Enrollment Status: Completed
Publish Date: September 03, 2025
Intervention Type: Biological
Study Drugs: ChAdOx1 COVID-19 Vaccine, MenACWY COVID-19 Vaccine, Paracetamol
Study Phase: Phase 2/Phase 3

85 Total Publications

Protocol for a phase IV, Experimental Human Pneumococcal Challenge (EHPC) model to investigate Streptococcus pneumoniae serotype 3 (SPN3) colonisation following PCV15, a double-blind randomised controlled trial in healthy participants aged 18-50 years in the UK (RATIONALE-15).
Protocol for a phase IV, Experimental Human Pneumococcal Challenge (EHPC) model to investigate Streptococcus pneumoniae serotype 3 (SPN3) colonisation following PCV15, a double-blind randomised controlled trial in healthy participants aged 18-50 years in the UK (RATIONALE-15).
Journal: BMJ open
Published: November 25, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Collins's expertise for a condition
ConditionClose
    View All 9 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile